Carcinoma in situRASSF1A average methylation was 17% ± 12.5% versus invasive breast cancer 27.4% ± 17%, confirming previous reports that RASSF1A methylation may be associated with the degree of cancer invasion and be an early event in breast cancer. The gene discussed is RASSF1; the disease is breast carcinoma.